Affordable Access

deepdyve-link
Publisher Website

Dosing and monitoring of low-molecular-weight heparin in high-risk pregnancy: single-center experience.

Authors
  • Shapiro, Nancy L
  • Kominiarek, Michelle A
  • Nutescu, Edith A
  • Chevalier, Aimee B
  • Hibbard, Judith U
Type
Published Article
Journal
Pharmacotherapy
Publication Date
Jul 01, 2011
Volume
31
Issue
7
Pages
678–685
Identifiers
DOI: 10.1592/phco.31.7.678
PMID: 21923455
Source
Medline
License
Unknown

Abstract

Dose changes for LMWH throughout pregnancy as guided by antifactor Xa activity were common. A significant increase in the LMWH dose requirements in the prophylactic group suggests that more frequent monitoring of antifactor Xa activity may be appropriate in pregnant patients to maintain target anticoagulant levels.

Report this publication

Statistics

Seen <100 times